Clinical & Pharma

A high-stakes convergence of science and policy recently unfolded in Doylestown, Bucks County, as National Institutes of Health (NIH) Director Dr. Jay Bhattacharya accepted an invitation from Congressman Brian Fitzpatrick (PA-1) for a firsthand look at a thriving hub of biomedical innovation. The

After a period of cautious investor sentiment that chilled the life sciences sector, Aktis Oncology is making a decisive move into the public domain with an initial public offering that could signal a significant turning point for the industry. The company, a specialist in targeted

Health authorities have issued urgent warnings as the highly contagious measles virus continues its resurgence, with notable outbreaks reminding communities of the persistent threat posed by vaccine-preventable diseases. The ease of modern travel has transformed localized clusters into

In the rapidly evolving pharmaceutical landscape, a fundamental strategic shift is underway as the very definition of a valuable brand is being rewritten. While individual product brands like Ozempic and Mounjaro have achieved unprecedented celebrity status and captured the public imagination,

A pervasive shadow economy now accounts for nearly one out of every five alcoholic beverages consumed in South Africa, creating a multi-faceted crisis that poses an escalating threat to public health, economic stability, and national security. This thriving underground market, valued at an

For many frail older adults, a major surgical procedure represents not the end of a health crisis but the beginning of a profound and often isolating journey that challenges their very sense of self. The stark reality is that the recovery process extends far beyond the healing of physical wounds,